New multifocal could help AMD patients
Arthur Cummings
Published: Sunday, April 19, 2015
A new multifocal IOL could help patients with macular disease maintain daily functioning with less dependence on low vision aids, reported Gerd Auffarth MD University of Heidelberg Eye Clinic, at the annual meeting of the American Society of Cataract and Refractive Surgery in San Diego.
Dr Auffarth reported his very early experience with the LENTIS Mplus High Add IOL in eight AMD patients being treated for cataract. It is an aspheric multifocal IOL with a biconvex optic that includes a sector-shaped near addition. Its overall length is 11.0 mm, with a 6.0 mm optic. With an 8.00 D near addition, this IOL has the potential to be very useful in patients with AMD because it translates to 6.00 D of near correction on the spectacle plane and has 1.5 times magnifying power, he explained.
The early experience was very positive, with all patients showing significant improvements in functional activities such as cooking, handwriting, and reading. Patients were able to reduce or eliminate their reliance on low vision loupes. In addition, perhaps because of the nature of the disease, patients reported no problems with glare or haloes. A multicentre trial is now underway in Europe with the IOL.
Latest Articles
Addressing Postoperative Visual Complications
Managing aberrations after laser refractive surgery requires a multi-layered approach.
3D Printing Helps Transform Ukrainian Eye Care
The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.
Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation
Emerging Microbial Trends That Could Affect Your Practices
A triptych of challenges paints a concerning picture for ophthalmologists across the globe.
Improving Outcomes with Laser-Assisted Surgery
Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.
Could the Corneal Transplant Pool Increase?
Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.
Matching Premium IOLs to Visual Lifestyles
From monofocal to full-range solutions, each practice needs comprehensive understanding.
Going Dutch on Acanthamoeba Keratitis
A world-first trial suggests a new medication could beat the disease.
Avoiding Intracorneal Ring Segment Complications
Femtosecond lasers are helping improve refractive results with fewer problems.